Autopsy, situated in the bustling heart of London, stands as a beacon of innovation in the data and analytics realm, chiefly focusing on deciphering trends in startup failures. By meticulously analyzing the roots of company failures and extracting indicators from these analyses, Autopsy aims to be a guiding light for both existing and upcoming startups, helping them navigate around common industry pitfalls. Moreover, this initiative serves as a potent tool for investors, offering them a rich dataset to facilitate informed investment decisions.Drawing from over 2000 narratives of failed startups, Autopsy harnesses the power of data science, machine learning, and predictive analytics to offer critical insights into business performance metrics and risk identification at the earliest stages. In its pursuit to redefine business analysis, the firm is crafting an automated auditing technology that promises to deliver unprecedented insights into business operations and industry benchmarks at various developmental stages. Serving a plethora of stakeholders including startups, scale-ups, venture capitalists, and industry analysts, Autopsy emerges as a versatile tool that promises to reshape the industry standards for business analysis and risk management.